Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells

Integrative Biology

Volumn 3, Issue 7, 2011, Pages 742-754

  Wang, Lei ^a   Alcon, Andre ^a   Yuan, Hongwei ^a   Ho, Jeffrey ^a   Li, Qi Jing ^b   Martins Green, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ANILINE; ANTIMETASTATIC AGENT; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CLAUDIN 1; COLLAGEN TYPE 1; HYALURONAN MEDIATED MOTILITY RECEPTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MICRORNA; MICRORNA 126; MICRORNA 200; MICRORNA 205; MICRORNA 21; MICRORNA 335; MICRORNA 373; MYRISTOYLATED ALANINE RICH PROTEIN KINASE C SUBSTRATE; POMEGRANATE EXTRACT; PROTEIN KINASE C EPSILON; RANTES; RECEPTOR PROTEIN; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1ALPHA; TROPOMYOSIN; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL DEATH; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; METASTASIS INHIBITION; MICROARRAY ANALYSIS; POMEGRANATE JUICE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD44; BEVERAGES; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINES; COLLAGEN TYPE I; EXTRACELLULAR MATRIX PROTEINS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICRORNAS; NEOPLASMS, HORMONE-DEPENDENT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; PUNICACEAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

LYTHRACEAE;

EID: 79959975747     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c0ib00122h     Document Type: Article

References (54)

1. F. Stavridi E. M. Karapanagiotou K. N. Syrigos Targeted therapeutic approaches for hormone-refractory prostate cancer Cancer Treat. Rev. 2010 36 122 130 10.1016/j.ctrv.2009.06.001
2. D. S. Coffey and K. J. Pienta, in Current Concepts and Approaches to the Study of Prostate Cancer, 1987, pp. 1-74
3. D. Schrijvers P. Van Erps J. Cortvriend Castration-refractory prostate cancer: new drugs in the pipeline Adv. Ther. 2010 27 285 296 10.1007/s12325-010-0038-1
4. C. S. Higano E. J. Small P. Schellhammer U. Yasothan S. Gubernick P. Kirkpatrick P. W. Kantoff Sipuleucel-T Nat. Rev. Drug Discovery 2010 9 513 514 10.1038/nrd3220
5. E. A. M. Schenk Re: Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer Eur. Urol. 2010 58 632 633 10.1016/j.eururo.2010.07.016
6. S. Shah C. J. Ryan Abiraterone acetate CYP17 inhibitor oncolytic Drugs Fut. 2009 34 873 880 10.1358/dof.2009.34.11.1441113
7. H. I. Scher T. M. Beer C. S. Higano A. Anand M.-E. Taplin E. Efstathiou D. Rathkopf J. Shelkey E. Y. Yu J. Alumkal D. Hung M. Hirmand L. Seely M. J. Morris D. C. Danila J. Humm S. Larson M. Fleisher C. L. Sawyers F. Prostate Canc Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study Lancet 2010 375 1437 1446 10.1016/S0140-6736(10)60172-9
8. A. J. Pantuck J. T. Leppert N. Zomorodian N. Seeram D. Seiler H. Liker H.-j. Wang R. Elashoff D. Heber A. S. Belldegrun Phase II study of pomegranate juice for men with rising PSA following surgery or radiation for prostate cancer J. Urol. 2005 173 225 226
9. M. Albrecht W. Jiang J. Kumi-Diaka E. P. Lansky L. M. Gommersall A. Patel R. E. Mansel I. Neeman A. A. Geldof M. J. Campbell Pomegranate extracts potently suppress proliferation, xenograft growth and invasion of human prostate cancer cells J. Med. Food 2004 7 274 283 (Pubitemid 39299484)
10. D. N. Syed Y. Suh F. Afaq H. Mukhtar Dietary agents for chemoprevention of prostate cancer Cancer Lett. 2008 265 167 176 10.1016/j.canlet.2008.02.050
11. M. B. Rettig D. Heber J. An N. P. Seeram J. Y. Rao H. Liu T. Klatte A. Belldegrun A. Moro S. M. Henning D. Mo W. J. Aronson A. Pantuck Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappa B-dependent mechanism Mol. Cancer Ther. 2008 7 2662 2671 10.1158/1535-7163.MCT-08-0136
12. A. Malik F. Afaq S. Sarfaraz V. M. Adhami D. N. Syed H. Mukhtar Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer Proc. Natl. Acad. Sci. U. S. A. 2005 102 14813 14818 (Pubitemid 41457138)
13. E. P. Lansky W. Jiang H. Mo L. Bravo P. Froom W. Yu N. M. Harris I. Neeman M. J. Campbell Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions Invest. New Drugs 2005 23 11 20 (Pubitemid 39516965)
14. D. Piomelli Arachidonic acid in cell signaling Curr. Opin. Cell Biol. 1993 5 274 280 (Pubitemid 23239781)
15. D. Nie M. Che D. Grignon K. Tang K. V. Honn Role of eicosanoids in prostate cancer progression Cancer Metastasis Rev. 2001 20 195 206 (Pubitemid 34595268)
16. K. V. Honn R. S. Bockman L. J. Marnett Prostaglandins and cancer a review of tumor initiation through tumor metastasis Prostaglandins Other Lipid Mediators 1981 21 833 864
17. A. Chaudry S. McClinton L. E. F. Moffat K. W. J. Wahle Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease Br. J. Cancer 1991 64 1157 1160
18. F. A. Attiga P. M. Fernandez A. T. Weeraratna M. J. Manyak S. R. Patierno Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases Cancer Res. 2000 60 4629 4637 (Pubitemid 32103650)
19. F. C. Hamdy E. J. Fadlon D. Cottam J. Lawry W. Thurrell P. B. Silcocks J. B. Anderson J. L. Williams R. C. Rees Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia Br. J. Cancer 1994 69 177 182 (Pubitemid 24021844)
20. C. E. Brinckerhoff L. M. Matrisian Matrix metalloproteinases: A tail of a frog that became a prince Nat. Rev. Mol. Cell Biol. 2002 3 207 214
21. K. Kessenbrock V. Plaks Z. Werb Matrix metalloproteinases: regulators of the tumor microenvironment Cell 2010 141 52 67 10.1016/j.cell.2010.03.015
22. Q. Zhou B. Yan X. Hu X.-B. Li J. Zhang J. Fang Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin Mol. Cancer Ther. 2009 8 1684 1691 10.1158/1535-7163.MCT-09-0191
23. J. P. Thiery Epithelial-mesenchymal transitions in tumour progression Nat. Rev. Cancer 2002 2 442 454
24. R. S. Taichman C. Cooper E. T. Keller K. J. Pienta N. S. Taichman L. K. McCauley Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone Cancer Res. 2002 62 1832 1837 (Pubitemid 34408510)
25. G. A. Calin C. M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 2006 6 857 866 10.1038/nrc1997 (Pubitemid 44629897)
26. A. Aderem The MARCKS brothers: A family of protein kinase C substrates Cell 1992 71 713 716
27. A. Rosen K. F. Keenan M. Thelen A. C. Nairn A. Aderem Activation of protein kinase c results in the displacement of its myristoylated alanine-rich substrate from punctate structures in macrophage filopodia J. Exp. Med. 1990 172 1211 1216
28. A. Arbuzova A. A. P. Schmitz G. Vergeres Cross-talk unfolded: MARCKS proteins Biochem. J. 2002 362 1 12 (Pubitemid 34174456)
29. S.-L. Lin D. Chang S.-Y. Ying Hyaluronan stimulates transformation of androgen-independent prostate cancer Carcinogenesis 2007 28 310 320 (Pubitemid 46321846)
30. M. Glotzer The molecular requirements for cytokinesis Science 2005 307 1735 1739 (Pubitemid 40388608)
31. T. Ohtsuka H. Nakanishi W. Ikeda A. Satoh Y. Momose H. Nishioka Y. Takai Nexilin: A novel actin filament-binding protein localized at cell-matrix adherens junction J. Cell Biol. 1998 143 1227 1238 (Pubitemid 28559824)
32. W. Wu M. Sun G.-M. Zou J. Chen MicroRNA and cancer: Current status and prospective Int. J. Cancer 2007 120 953 960 10.1002/ijc.22454 (Pubitemid 46214293)
33. X.-B. Shi C. G. Tepper R. W. d. White microRNAs and prostate cancer J. Cell. Mol. Med. 2008 12 1456 1465 10.1111/j.1582-4934.2008.00420.x
34. S. F. Tavazoie C. Alarcon T. Oskarsson D. Padua Q. Wang P. D. Bos W. L. Gerald J. Massague Endogenous human microRNAs that suppress breast cancer metastasis Nature 2008 451 147 10.1038/nature06487
35. T. Tsunoda H. Inada I. Kalembeyi K. Imanaka-Yoshida M. Sakakibara R. Okada K. Katsuta T. Sakakura Y. Majima T. Yoshida Involvement of large tenascin-C splice variants in breast cancer progression Am. J. Pathol. 2003 162 1857 1867 (Pubitemid 36613044)
36. P. Gandellini M. Folini N. Longoni M. Pennati M. Binda M. Colecchia R. Salvioni R. Supino R. Moretti P. Limonta R. Valdagni M. G. Daidone N. Zaffaroni miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase C epsilon Cancer Res. 2009 69 2287 2295 10.1158/0008-5472.CAN-08-2894
37. D. Wu T. L. Foreman C. W. Gregory M. A. McJilton G. G. Wescott O. H. Ford R. F. Alvey J. L. Mohler D. M. Terrian Protein kinase Cepsilon has the potential to advance the recurrence of human prostate cancer Cancer Res. 2002 62 2423 2429 (Pubitemid 34411727)
38. C. Yang M. G. Kazanietz Chimaerins: GAPs that bridge diacylglycerol signalling and the small G-protein Rac Biochem. J. 2007 403 1 12 10.1042/BJ20061275 (Pubitemid 46706985)
39. M. Korpal E. S. Lee G. Hu Y. Kang The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 J. Biol. Chem. 2008 283 14910 14914 10.1074/jbc.C800074200
40. W. Birchmeier J. Behrens Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness Biochim. Biophys. Acta 1994 1198 11 26 (Pubitemid 24159061)
41. A. Musiyenko V. Bitko S. Barik Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells J. Mol. Med. 2008 86 313 322 10.1007/s00109-007-0296-9
42. S. Zhu H. Wu F. Wu D. Nie S. Sheng Y.-Y. Mo MicroRNA-21 targets tumor suppressor genes in invasion and metastasis Cell Res. 2008 18 350 359 10.1038/cr.2008.24 (Pubitemid 351333899)
43. T. Li D. Li J. Sha P. Sun Y. Huang MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells Biochem. Biophys. Res. Commun. 2009 383 280 285 10.1016/j.bbrc.2009.03.077
44. S. V. Perry Vertebrate tropomyosin: distribution, properties and function J. Muscle Res. Cell Motil. 2001 22 5 49 (Pubitemid 32831636)
45. H.-S. Yang A. P. Jansen A. A. Komar X. Zheng W. C. Merrick S. Costes S. J. Lockett N. Sonenberg N. H. Colburn The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation Mol. Cell. Biol. 2003 23 26 37 (Pubitemid 36008498)
46. Q. Huang K. Gumireddy M. Schrier C. le Sage R. Nagel S. Nair D. Egan A. Li G. Huang A. Klein-Szanto G. Phyllis D. Katsaros G. Coukos L. Zhang E. Pure R. Agami The micrornas mir-373 and mir-520c promote tumor migration, invasion and metastasis Proceedings of the American Association for Cancer Research Annual Meeting 2008 49 1196 1197
47. A. L. Omara-Opyene J. Qiu G. V. Shah K. A. Iczkowski Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18 Lab. Invest. 2004 84 894 907 (Pubitemid 38833249)
48. H. Steiner S. Godoy-Tundidor H. Rogatsch A. P. Berger D. Fuchs B. Comuzzi G. Bartsch A. Hobisch Z. Culig Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway Am. J. Pathol. 2003 162 655 663 (Pubitemid 36267872)
49. Z. Culig H. Steiner G. Bartsch A. Hobisch Interleukin-6 regulation of prostate cancer cell growth J. Cell. Biochem. 2005 95 497 505 (Pubitemid 41420180)
50. H. Steiner A. P. Berger S. Godoy-Tundidor A. Bjartell H. Lija G. Bartsch A. Hobisch Z. Culig An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6 Eur. J. Cancer 2004 40 1066 1072 (Pubitemid 38496265)
51. A. M. Cooper S. A. Khader IL-12p40: an inherently agonistic cytokine Trends Immunol. 2007 28 33 38 (Pubitemid 44960157)
52. M. Yamamoto H. Kikuchi M. Ohta T. Kawabata Y. Hiramatsu K. Kondo M. Baba K. Kamiya T. Tanaka M. Kitagawa H. Konno TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche Cancer Res. 2008 68 9754 9762 10.1158/0008-5472.CAN-08-1748
53. R. N. Apte S. Dotan M. Elkabets M. R. White E. Reich Y. Carmi X. Song T. Dvozkin Y. Krelin E. Voronov The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions Cancer Metastasis Rev. 2006 25 387 408 (Pubitemid 44922357)
54. G. G. Vaday D. M. Peehl P. A. Kadam D. M. Lawrence Expression of CCL5 (RANTES) and CCR5 in prostate cancer Prostate 2006 66 124 134 (Pubitemid 43191234)